Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk Acute Myeloid Leukemia”

63 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 63 results

Testing effectiveness (Phase 2)Looking for participantsNCT04049539
What this trial is testing

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

Who this might be right for
Blasts More Than 5 Percent of Bone Marrow Nucleated CellsPersistent DiseaseRefractory Acute Myeloid Leukemia
Ohio State University Comprehensive Cancer Center 28
Not applicableLooking for participantsNCT06529250
What this trial is testing

Intermediate-dose HAD Regimen for CEBPA Double-mutated AML

Who this might be right for
AML
Institute of Hematology & Blood Diseases Hospital, China 148
Large-scale testing (Phase 3)Enrolling By InvitationNCT07537257
What this trial is testing

VEN+IDAC vs IDAC in AML

Who this might be right for
AML (Acute Myelogenous Leukemia)
Guangdong Second Provincial General Hospital 232
Large-scale testing (Phase 3)Ended earlyNCT01246752
What this trial is testing

Haematopoietic Stem Cell Transplantation (HSCT) in Comparison to Conventional Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) (Intermediate Risk) </= 60y. After First CR

Who this might be right for
Leukemia, Myeloid, Acute
University Hospital Carl Gustav Carus 143
Post-approval studies (Phase 4)Study completedNCT00180102
What this trial is testing

AML2003 - Standard-Therapy vs Intensified Therapy for Adult Acute Myeloid Leukemia Patients <= 60 Years

Who this might be right for
Leukemia, Nonlymphocytic, Acute
Technische Universität Dresden 600
Testing effectiveness (Phase 2)UnknownNCT02428543
What this trial is testing

Ponatinib for FLT3-ITD Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Lukemia
Versailles Hospital 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT02935361
What this trial is testing

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes
University of Southern California 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05599360
What this trial is testing

Vyxeos for Induction of Low- or Intermediate-risk.

Who this might be right for
Leukemia, Myeloid, Acute
Shaare Zedek Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01690507
What this trial is testing

Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML）

Who this might be right for
MDSAML
Chinese PLA General Hospital 29
Large-scale testing (Phase 3)UnknownNCT01414231
What this trial is testing

Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a

Who this might be right for
Acute Myeloid Leukaemia
University of Leipzig 850
Testing effectiveness (Phase 2)Looking for participantsNCT07304232
What this trial is testing

Post-transplantation Maintenance Therapy With Cidabenamide in Patients With Intermediate/High-risk AML

Who this might be right for
Allogeneic Hematopoietic Cell Transplantation (HCT)AML (Acute Myeloid Leukemia)
Institute of Hematology & Blood Diseases Hospital, China 134
Not applicableUnknownNCT03751917
What this trial is testing

Long-term Safety Study of Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk Acute Promyelocytic Leukemia

Who this might be right for
Acute Promyelocytic Leukemia
Gruppo Italiano Malattie EMatologiche dell'Adulto 100
Large-scale testing (Phase 3)UnknownNCT05175508
What this trial is testing

Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS

Who this might be right for
AMLMDSOld Age; Debility+1 more
The First Affiliated Hospital of Soochow University 180
Large-scale testing (Phase 3)Active Not RecruitingNCT05883956
What this trial is testing

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelomonocytic, Chronic+1 more
Otsuka Australia Pharmaceutical Pty Ltd 13
Testing effectiveness (Phase 2)UnknownNCT03417427
What this trial is testing

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Who this might be right for
Leukemia, Myeloid
Xuejie Jiang 100
Testing effectiveness (Phase 2)Looking for participantsNCT07259707
What this trial is testing

Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML

Who this might be right for
Acute Myeloid LeukemiaFLT3 Internal Tandem Duplication PositiveIntermediate Risk Acute Myeloid Leukemia+1 more
First Affiliated Hospital of Zhejiang University 25
Large-scale testing (Phase 3)Active Not RecruitingNCT03897127
What this trial is testing

Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics

Who this might be right for
Acute Myeloid Leukemia
University of Ulm 882
Testing effectiveness (Phase 2)Study completedNCT03338348
What this trial is testing

Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)
University of Ulm 9
Early research (Phase 1)Study completedNCT04402541
What this trial is testing

Study of CB-5339 in Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid Leukemia, in RelapseMyelodysplastic Syndromes
Cleave Therapeutics, Inc. 55
Large-scale testing (Phase 3)Ended earlyNCT03926624
What this trial is testing

Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage

Who this might be right for
Leukemia, Myeloid, Acute
Delta-Fly Pharma, Inc. 167
Load More Results